Unlocking valuable autoantigen insight

  • ORVAR identifies all possible autoantigens within a patient cohort at a given time that are associated with a disease.
  • We then use our patented KREX® technology to clone, express, and attach all autoantigens to create and validate a Sengenics protein array.
  • This protein array serves as a validated, true positive, disease-specific autoantigen library.
  • Applications include the discovery of autoantibody signatures for development of early diagnostics, patient stratification, and drug response prediction.